The clinical course of mannosidosis
- PMID: 7149616
The clinical course of mannosidosis
Abstract
The clinical course of mannosidosis was studied in eight patients. The age at onset of symptoms varied from 6 months to 3 years. The first symptom was usually delayed development of speech or motor or mental functions and was often accompanied by recurrent infections. All the patients were mentally retarded, with slightly coarse facial features, poor ability to speak, sensorineural hearing loss and dysostosis multiplex. Ataxia was seen in all but one case, appearing in childhood at the same time as the hearing loss. Follow-up observations suggested gradual impairment of mental and motor functions and speech with age. Other findings were stunted growth in adults, and vacuolated lymphocytes in the peripheral blood.
Similar articles
-
[Mannosidosis: a simple diagnosis].Arch Fr Pediatr. 1976 Jan;33(1):11-22. Arch Fr Pediatr. 1976. PMID: 985028 French.
-
Speech and language development in a population of Swedish hearing-impaired pre-school children, a cross-sectional study.Int J Pediatr Otorhinolaryngol. 2007 Jul;71(7):1061-77. doi: 10.1016/j.ijporl.2007.03.016. Epub 2007 May 18. Int J Pediatr Otorhinolaryngol. 2007. PMID: 17512613
-
Inner ear and facial nerve complications of acute otitis media with focus on bacteriology and virology.Acta Otolaryngol. 2006 May;126(5):460-6. doi: 10.1080/00016480500401043. Acta Otolaryngol. 2006. PMID: 16698694
-
[Mannosidosis. Clinical and enzymatic studies in a family].Neurologia. 1986 Mar-Apr;1(2):58-62. Neurologia. 1986. PMID: 3079111 Review. Spanish. No abstract available.
-
Factors associated with sensorineural hearing loss among survivors of extracorporeal membrane oxygenation therapy.Pediatrics. 2005 Jun;115(6):1519-28. doi: 10.1542/peds.2004-0247. Pediatrics. 2005. PMID: 15930212 Review.
Cited by
-
Natural history of alpha mannosidosis a longitudinal study.Orphanet J Rare Dis. 2013 Jun 20;8:88. doi: 10.1186/1750-1172-8-88. Orphanet J Rare Dis. 2013. PMID: 23786919 Free PMC article. Clinical Trial.
-
Alpha-Mannosidosis: Therapeutic Strategies.Int J Mol Sci. 2018 May 17;19(5):1500. doi: 10.3390/ijms19051500. Int J Mol Sci. 2018. PMID: 29772816 Free PMC article. Review.
-
The Role of Hematopoietic Cell Transplant in the Glycoprotein Diseases.Cells. 2020 Jun 5;9(6):1411. doi: 10.3390/cells9061411. Cells. 2020. PMID: 32517081 Free PMC article. Review.
-
Intellectual functioning in alpha-mannosidosis.JIMD Rep. 2019 Sep 21;50(1):44-49. doi: 10.1002/jmd2.12073. eCollection 2019 Nov. JIMD Rep. 2019. PMID: 31741826 Free PMC article.
-
Neurocognitive and psychotiform behavioral alterations and enhanced hippocampal long-term potentiation in transgenic mice displaying neuropathological features of human alpha-mannosidosis.J Neurosci. 2005 Jul 13;25(28):6539-49. doi: 10.1523/JNEUROSCI.0283-05.2005. J Neurosci. 2005. PMID: 16014715 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical